Your browser doesn't support javascript.
loading
Cancer Progress and Priorities: Gastric Cancer.
Alagesan, Priya; Goodwin, Jessica C; Garman, Katherine S; Epplein, Meira.
Afiliação
  • Alagesan P; Duke University School of Medicine, Durham, North Carolina.
  • Goodwin JC; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
  • Garman KS; Morehouse School of Medicine, Atlanta, Georgia.
  • Epplein M; Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina.
Cancer Epidemiol Biomarkers Prev ; 32(4): 473-486, 2023 04 03.
Article em En | MEDLINE | ID: mdl-37009691
ABSTRACT
Gastric cancer, the fifth leading cause of cancer worldwide, is estimated to be responsible for approximately 1.4% of all new cancers and 1.8% of all cancer-related deaths in the United States. Despite declining incidence rates and improved survival rates, however, gastric cancer continues to disproportionately affect racial and ethnic minorities and individuals of lower socioeconomic status at higher rates than the general population. To improve outcomes globally and address disparities within the United States, continued improvements are needed in risk factor modification and biomarker development and to improve access to existing preventative measures such as genetic testing and H. pylori eradication testing, in addition to expanding upon current clinical guidelines for premalignant disease to address gaps in endoscopic surveillance and early detection.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões Pré-Cancerosas / Neoplasias Gástricas / Infecções por Helicobacter Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões Pré-Cancerosas / Neoplasias Gástricas / Infecções por Helicobacter Idioma: En Ano de publicação: 2023 Tipo de documento: Article